Compare Encompass Health Corp. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROCE of 18.36%
2
Poor long term growth as Net Sales has grown by an annual rate of 4.26% and Operating profit at 9.42% over the last 5 years
3
The company has declared Positive results for the last 7 consecutive quarters
4
With ROCE of 21.99%, it has a very expensive valuation with a 3.82 Enterprise value to Capital Employed
Stock DNA
Pharmaceuticals & Biotechnology
USD 10,002 Million (Small Cap)
21.00
NA
0.73%
0.83
30.33%
4.21
Revenue and Profits:
Net Sales:
1,478 Million
(Quarterly Results - Sep 2025)
Net Profit:
175 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.65%
0%
-13.65%
6 Months
-12.57%
0%
-12.57%
1 Year
-2.58%
0%
-2.58%
2 Years
38.62%
0%
38.62%
3 Years
61.91%
0%
61.91%
4 Years
107.83%
0%
107.83%
5 Years
52.24%
0%
52.24%
Encompass Health Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.26%
EBIT Growth (5y)
9.42%
EBIT to Interest (avg)
4.92
Debt to EBITDA (avg)
2.35
Net Debt to Equity (avg)
0.95
Sales to Capital Employed (avg)
1.22
Tax Ratio
18.96%
Dividend Payout Ratio
14.35%
Pledged Shares
0
Institutional Holding
98.82%
ROCE (avg)
18.36%
ROE (avg)
27.24%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
6.49
EV to EBIT
17.37
EV to EBITDA
13.02
EV to Capital Employed
3.82
EV to Sales
2.91
PEG Ratio
0.71
Dividend Yield
35.19%
ROCE (Latest)
21.99%
ROE (Latest)
30.29%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 134 Schemes (45.77%)
Foreign Institutions
Held by 208 Foreign Institutions (15.65%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
1,477.50
1,457.70
1.36%
Operating Profit (PBDIT) excl Other Income
326.00
339.00
-3.83%
Interest
30.80
30.40
1.32%
Exceptional Items
0.00
0.00
Consolidate Net Profit
174.70
185.40
-5.77%
Operating Profit Margin (Excl OI)
164.90%
177.70%
-1.28%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 1.36% vs 0.16% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -5.77% vs -5.70% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
5,373.20
4,801.20
11.91%
Operating Profit (PBDIT) excl Other Income
1,164.10
1,005.70
15.75%
Interest
137.40
143.50
-4.25%
Exceptional Items
-0.60
0.00
Consolidate Net Profit
596.60
472.60
26.24%
Operating Profit Margin (Excl OI)
160.90%
152.40%
0.85%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 11.91% vs 10.41% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 26.24% vs 35.18% in Dec 2023
About Encompass Health Corp. 
Encompass Health Corp.
Pharmaceuticals & Biotechnology
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice. It is an owner and operator of inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on both an inpatient and outpatient basis. It offers its home health and hospice services through Encompass Home Health and Hospice business (Encompass). Encompass operates home health and hospice agencies in 30 states, with concentrations in the Southeast, Oklahoma, and Texas. As of December 31, 2018, the Company operated 130 inpatient rehabilitation hospitals.
Company Coordinates 
Company Details
9001 Liberty Pkwy , BIRMINGHAM AL : 35242-7509
Registrar Details






